WE-Pharma SRL
19.6 FTEThe score of WE-Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +947 % Total assets +172 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
WE-Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Sep 2026
- Year ended 31 Dec 2024filed on 07 Jul 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
- Year ended 31 Dec 2022filed on 31 Jul 2023
- Year ended 31 Dec 2021filed on 20 Sep 2022
WE-Pharma's financial analysis
- Solvency30.7%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of WE-Pharma
WE-Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0810.070.556
- VAT number
- BE0810070556
- Peppol
- Registered · 0208:0810070556 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 26 Feb 2009
- Registered office
- 4500 Huy
- Size
- Small · 19.6 FTE
- Latest accounts
- 2025 · filed on 30 Sep 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
WE-Pharma (SRL) has been based in Huy since 2009, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of €2.24m and equity of €1.39m; its revenue is not published. With 19.6 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 30.7%, below the median of its sector (41.5%).
Companies similar to WE-Pharma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Lamoot Retail sale of pharmaceutical products Ypres · balance sheet €4.63m
- Pharmacie Anselme Retail sale of pharmaceutical products Antoing · balance sheet €4.76m
- Hainapharma Retail sale of pharmaceutical products Aiseau-Presles · balance sheet €4.03m
- Imbefrance Retail sale of pharmaceutical products Halle · balance sheet €5.11m
- Dansaert Retail sale of pharmaceutical products Brussels · balance sheet €3.93m
- Alpaga MDB Retail sale of pharmaceutical products Kontich · balance sheet €5.32m
- Patrimanne Retail sale of pharmaceutical products Stekene · balance sheet €3.82m
- Apophar Retail sale of pharmaceutical products Ixelles · balance sheet €5.33m
Frequently asked questions about WE-Pharma
What is the revenue of WE-Pharma?
WE-Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of WE-Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0810070556 for WE-Pharma, if the company is VAT-registered. Its company number (CBE) is 0810.070.556.
Where is the registered office of WE-Pharma?
According to the CBE register, the registered office of WE-Pharma is in 4500 Huy.
What is the equity of WE-Pharma?
At the close of the 2025 financial year, the equity of WE-Pharma amounts to 1,385,519 €, a solvency of 30.7% of total assets.
How many people work at WE-Pharma?
19.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages WE-Pharma?
The register lists 9 active mandates at WE-Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of WE-Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →